🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 for elderly patients — anyone have experience?

Oral GLP-1 for elderly patients — anyone have experience?

EndoResFellow Sat, Jul 12, 2025 at 4:27 AM 45 replies 2,071 viewsPage 1 of 9
This thread is more than 11 months old. Information may be outdated. Consider searching for more recent discussions.
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jul 12, 2025 at 4:27 AM#1

On 25mg oral, four months in, and my results are closer to the low-dose injectable arm than to the numbers being quoted for 50mg.

The question I want answered is how much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly.

Happy to be told the question itself is wrong.

3 23robert_kc, dan_philly, MeganSA_TX
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Jul 12, 2025 at 5:34 AM#2

Short answer first, then the reasoning. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

Correct me if the detail matters more than I have assumed.

Last edited: Jul 12, 2025 at 9:34 AM
2 22newstart_MO, mia_MS2
Reply Quote Save Share Report
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Jul 12, 2025 at 6:41 AM#3
mike.trainer_LA said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

mike.trainer_LA has the substance of this right. The condition it depends on is worth stating. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

1 21Dr.ObesityMed
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Jul 12, 2025 at 7:48 AM#4
EndoResFellow said:
On 25mg oral, four months in, and my results are closer to the low-dose injectable arm than to the numbers being quoted for 50mg.

Can confirm the pattern EndoResFellow describes. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

50 20lori_vegas, Dr.PulmRoch, maya_sedona and 47 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jul 12, 2025 at 2:15 PM#5

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Jul 12, 2025 at 3:15 PM
49 19FranDenver, Dr.BariatricHTX, LindaRN_retired and 46 others
Reply Quote Save Share Report
1239

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register